By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: What the FDA Is and Isn’t Doing During the Government Shutdown
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > News > What the FDA Is and Isn’t Doing During the Government Shutdown
NewsPolicy & Law

What the FDA Is and Isn’t Doing During the Government Shutdown

Deanna Pogorelc
Deanna Pogorelc
Share
3 Min Read
SHARE

fda government shutdown

There’s been lots of speculation as to what the government shutdown means for the U.S. Food and Drug Administration — including various reports that our food isn’t getting inspected.

fda government shutdown

There’s been lots of speculation as to what the government shutdown means for the U.S. Food and Drug Administration — including various reports that our food isn’t getting inspected.

More Read

Image
IVF: The Three Biggest Myths
The Top 5 Mistakes Hospitals with High Readmission Rates Are Making
Health Information Technology: Whistling by the Graveyard
Best Exercises to Rehab a Torn ACL Without Special Equipment
Caring For Chronic Illnesses Should Be Different

Just over half of the FDA staff members are still working. Those not furloughed are those who perform vital roles around the safety of human life, high-risk recalls, civil and criminal investigations, or certain activities authorized to be funded by carried-over industry user fees.

In large part, it appears that medical products will continue to be reviewed and regulated as usual, according to a memo posted by the FDA. Instead, the FDA is sacrificing much of its oversight of food safety, nutrition and cosmetics, and pausing most laboratory research. But there are still a few implications for the medical device, biotech and pharmaceutical industries.

While the government is shutdown, the FDA can’t collect any user fees assessed for FY2014. Therefore, it can’t accept any regulatory submissions for FY2014 that require a fee, like new drug applications, premarket applications, product development protocols and 510(k)s, unless the fee payment was made before Oct. 1. The House of Representatives voted Monday to restore funding to FDA through the rest of the shutdown, but the measure would still need to pass the Senate to go into effect.

Meanwhile, FDA will continue to accept applications for which the fee has been paid, and applications for which no fee is required, including investigational new drug applications, humanitarian device exemptions, investigational device exemptions and de novos.

So long as resources allow, the FDA said it will continue to also review those medical product applications, although it made a special point to note that certain review activities for medical devices may be suspended due to resource constraints. It approved two new drugs last week.

With regard to biosimilars, the FDA said it doesn’t expect to have access to any Biosimilar User Fee Act funding and won’t perform any review activity in this area, except for emergency work.

Generally, the FDA said, scheduled advisory committee meetings would go continue as scheduled. That’s good news for the several pharma and biotech companies that have pending FDA reviews scheduled for October.

Meanwhile, other branches of HHS have taken bigger hits. The CDC, for example, has paused its influenza tracking program, and the NIH is not admitting new patients to its clinical trials.

[Image credit: Flickr user Magic Madzik]

TAGGED:FDAgovernment shutdown
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

kratom has many health benefits
News

5 Simple Ways To Know That MIT45 Kratom Liquids Are Genuine

November 15, 2022

Why You Don’t Have Real Health Insurance

September 29, 2011

Making Cigarette Smoking Uncool

June 27, 2011
HIPAA, content marketing
BusinessHospital AdministrationPolicy & Law

Keeping Your Content Marketing HIPAA-Compliant

October 7, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?